Cardiome Pharma Corp. (USA) (NASDAQ:CRME)

CAPS Rating: 3 out of 5

Life sciences company focused on developing proprietary drugs to treat or prevent cardiovascular diseases. Current efforts are focused on the treatment of atrial arrhythmias and congestive heart failure.

Recs

0
Player Avatar Roadkillguam (79.43) Submitted: 9/8/2009 8:19:30 AM : Outperform Start Price: $4.48 CRME Score: -122.57

Port

Featured Broker Partners


Advertisement